Last updated: 11/07/2018 10:20:47

Cost of illness associated with influenza in the UK

GSK study ID
116313
See study documents
Clinicaltrials.gov ID
NCT01521416
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Finalized
Finalized
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: The cost of illness associated with influenza in the UK
Trial description: The objective of this study is to describe the burden associated with influenza in the UK, from both primary and secondary care perspectives, and to stratify the burden by the annual degree of mismatch between predicted and actual virus strains.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:

Incidence of influenza-related events

Timeframe: Over the study time period (from January 21st 2001 to March 31st 2009 inclusive)

Number of confirmed influenza infections

Timeframe: Over the study time period (from January 21st 2001 to March 31st 2009 inclusive)

Assessment of resource use

Timeframe: Over the study time period (from January 21st 2001 to March 31st 2009 inclusive)

Evaluation of patient outcomes, treatments and costs (type and duration)

Timeframe: Over the study time period (from January 21st 2001 to March 31st 2009 inclusive)

Cause of deaths

Timeframe: Over the study time period (from January 21st 2001 to March 31st 2009 inclusive)

Incidence of influenza-related events in High Risk groups

Timeframe: Over the study time period (from January 21st 2001 to March 31st 2009 inclusive)

Incidence of complications and exacerbations

Timeframe: Over the study time period (from January 21st 2001 to March 31st 2009 inclusive)

Secondary outcomes:
Not applicable
Interventions:
Other: Data collection
Enrollment:
1
Observational study model:
Case-Only
Primary completion date:
Not applicable
Time perspective:
Retrospective
Clinical publications:
Pockett RD et al. (2015) Burden of illness in UK subjects with reported respiratory infections vaccinated or unvaccinated against influenza: A retrospective observational study. PLoS One. 10(8):e0134928.
Medical condition
Influenza
Product
GSK2647158A
Collaborators
Not applicable
Study date(s)
June 2011 to April 2013
Type
Observational
Phase
Not applicable

Participation criteria

Sex
Female & Male
Age
5 - 65 years
Accepts healthy volunteers
No
  • Male or female patients coded within the database as having acute respiratory events that could be related to an infection between 2001 and 2009.
  • Patients must have a minimum of 14 days observation before and after the index event to permit the capturing of complications attributable to influenza.
  • Not Applicable
Inclusion and exclusion criteria
Inclusion criteria:

    Male or female patients coded within the database as having acute respiratory events that could be related to an infection between 2001 and 2009.

    • Patients must have a minimum of 14 days observation before and after the index event to permit the capturing of complications attributable to influenza.
Exclusion criteria:
  • Not Applicable

Trial location(s)

No location data available.

Study documents

Scientific result summary
Available language(s): English
Download document(s)

If you wish to request for full study report, please contact - [email protected]

Results overview

Refer to study documents

Recruitment status
Finalized
Actual primary completion date
Not applicable
Actual study completion date
2013-30-04

Plain language summaries

Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

Additional information about the trial

Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website